Successful treatment of mucous membrane pemphigoid with tacrolimus

Special Care in Dentistry

Volumn 26, Issue 2, 2006, Pages 66-70

  Suresh, Lakshmanan ^a   Calixto, Luis Edmundo Martinez ^a   Radfar, Lida ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Mucous membrane pemphigoid; Oral lesions; Tacrolimus

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

AGED; ARTICLE; CASE REPORT; DRUG EFFECT; FEMALE; HUMAN; MOUTH MUCOSA; MOUTH ULCER; MUCOUS MEMBRANE PEMPHIGOID; PATHOLOGY; TREATMENT OUTCOME;

AGED; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MOUTH MUCOSA; ORAL ULCER; PEMPHIGOID, BENIGN MUCOUS MEMBRANE; TACROLIMUS; TREATMENT OUTCOME;

EID: 33744806050     PISSN: 02751879     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1754-4505.2006.tb01512.x     Document Type: Article

References (36)

1. Chan LS, Ahmed AR, Anhalt GJ, Bernauer W, Cooper KD, Elder MJ, et al. The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol 2002;138:370-9.
2. Chan LS. Mucous membrane pemphigoid. Clin Dermatol 2001;19:703-11.
3. Scully C, Carrozzo M, Gandolfo S, Puiatti P, Monteil R. Update on mucous membrane pemphigoid: a heterogeneous immune-mediated subepithelial blistering entity. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;88:56-68.
4. Liu Z. Immunopathology of bullous pemphigoid an autoimmune and inflammatory skin blistering disease. Keio J Med 2003;52:128-33.
5. Nisengard RJ. Periodontal implications: mucocutaneous disorders. Ann Periodontol 1996;1:401-38.
6. Stoopler ET, DeRossi SS, Sollecito TE Mucous membrane pemphigoid. Update for the general practitioner. NY State Dent J 2003;69:28-31.
7. Kirtschig G, Murrell D, Wojnarowska F, Khumalo N. Interventions for mucous membrane pemphigoid and epidermolysis bullosa acquisita. Cochrane Database Syst Rev 2003;1:CD004056.
8. Ciarrocca KN, Greenberg MS. A retrospective study of the management of oral mucous membrane pemphigoid with dapsone. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;88:159-63.
9. Rogers RS 3rd. Dapsone and sulfapyridine therapy of pemphigoid diseases. Australas J Dermatol 1986;27:58-63.
10. Brody HJ, Pirozzi DJ. Benign mucous membrane pemphigoid. Response to therapy with cyclophosphamide. Arch Dermatol 1977;113:1598-9.
11. Dave VK, Vickers CE Azathioprine in the treatment of muco-cutaneous pemphigoid. Br J Dermatol 1974;90:183-6.
12. Poskitt L, Wojnarowska F. Treatment of cicatricial pemphigoid with tetracycline and nicotinamide. Clin Exp Dermatol 1995;20:258-9.
13. Armitage JM, Kormos RL, Fung J, et al. The clinical trial of FK 506 as primary and rescue immunosuppression in adult cardiac transplantation. Transplant Proc 1991:23:3054-7.
14. Ruzicka T, Bieber T, Schopf E, Rubins A, Dobozy A, Bos JD, et al. A short-term trial of tacrolimus ointment for atopic dermatitis. N Engl J Med 1997;337:816-21.
15. The European FK 506 Multicentre Psoriasis Study Group. Systemic tacrolimus (FK 506) is effective for the treatment of psoriasis in a double-blind, placebo-controlled study. Arch Dermatol 1996;132:419-23.
16. Kaliakatsou F, Hodgson TA, Lewsey JD, Hegarty AM, Murphy AD, Porter SR. Management of recalcitrant ulcerative oral lichen planus with topical tacrolimus. J Am Acad Dermatol 2002;46:35-41.
17. Hodgson TA, Malik F, Hegarty AM, Porter SR. Topical tacrolimus: a novel therapeutic intervention for recalcitrant labial pemphigus vulgaris. Eur J Dermatol 2003;13:142-4.
18. Sánchez AR, Sheridan PJ, Rogers RS. Successful treatment of oral lichen planus-like chronic graft-versus-host disease with topical tacrolimus: a case report. J Periodontol 2004;75:613-9.
19. Gunther C, Wozel G, Meurer M, Pfeiffer C. Topical tacrolimus treatment for cicatricial pemphigoid. J Am Acad Dermatol 2004;50:325-6.
20. Chub AA. The application of topical tacrolimus in vesicular pemphigoid. Br J Dermatol 2004;150:622-3.
21. Hall VC, Liesegang TJ, Kostick DA, Lookingbill DP. Ocular mucous membrane pemphigoid and ocular pemphigus vulgaris treated topically with tacrolimus ointment. Arch Dermatol 2003;139:1083-4.
22. Letko E, Ahmed AR, Foster CS. Treatment of ocular cicatricial pemphigoid with tacrolimus (FK 506). Graefes Arch Clin Exp Ophthalmol 2001;239:441-4.
23. Fleming TE, Korman NJ. Cicatricial pemphigoid. J Am Acad Dermatol 2000;43:571-91.
24. Laskaris G, Angelopoulos A. Cicatricial pemphigoid: direct and indirect immunofluorescent studies. Oral Surg Oral Med Oral Pathol 1981;51:48-54.
25. Dayan S, Simmons RK, Ahmed R. Contemporary issues in the diagnosis of oral pemphigoid. A selective review of literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;88:424-30.
26. Musa NJ, Kumar V, Humphreys L, Aguirre A, Neiders ME. Oral pemphigoid masquerading as necrotizing ulcerative gingivitis in a child. J Periodontol 2002;73:657-63.
27. Delgado JC, Turbay D, Yunis EJ, et al. A common major histocompatibility complex class II allele HLA-DQ[beta] 1*0301 is present in clinical variants of pemphigoid. Proc Natl Acad Sci USA 93:8569-8571, 1996.
28. Budinger L, Borradori L, Yee C, et al. Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls. J Clin Invest 1998;102:2082-2089.
29. Silverman S Jr, Gorsky M, Lozada-Nur F, Liu A. Oral mucous membrane pemphigoid. A study of sixty-five patients. Oral Surg Oral Med Oral Pathol 1986;61:233-7.
30. Mobini N, Nagarwalla N, Ahmed AR. Oral pemphigoid. Subset of cicatricial pemphigoid? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;85:37-43.
31. Kelly PA, Burckart GJ, Venkataramanan R. Tacrolimus: A new immunosuppressive agent. Am J Health Syst Pharm 1995;52:1521-35.
32. Great IA, Mermelstein PG, Stankunas K, et al. L-type calcium channels and GSK-3 regulate the activity of NF-ATc4 in hippocampal neurons. Nature 1994;401:703-8.
33. Vente C, Reigh K, Rupprecht R, Neumann C. Erosive mucosal lichen planus: response to topical treatment with tacrolimus. Br J Dermatol 1999;140:338-42.
34. Hodgson TA, Sahni N, Kaliakatsou F, Buchanan JA, Porter SR. Long-term efficacy and safety of topical tacrolimus in the management of ulcerative/erosive oral lichen planus. Eur J Dermatol 2003;13:466-70.
35. Assmann T, Burchardt T, Becker J, Ruzicka T, Megahed M. Topical immunomodulators: a therapeutic option for oral cicatricial pemphigoid [Article in German]. Hautarzt 2004;55:390-2.
36. Shen JT, Pedvis-Leftick A. Mucosal staining after using topical tacrolimus to treat erosive oral lichen planus. J Am Acad Dermatol 2004;50:326.